151 related articles for article (PubMed ID: 32930401)
21. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
[TBL] [Abstract][Full Text] [Related]
22. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics.
Pelizzo MR; Pennelli G; Zane M; Galuppini F; Colletti PM; Merante Boschin I; Rubello D
Biomed Pharmacother; 2015 Aug; 74():9-16. PubMed ID: 26349957
[TBL] [Abstract][Full Text] [Related]
24. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
26. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
27. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
28. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.
Takeda T; Tsuji K; Banno K; Yanokura M; Kobayashi Y; Tominaga E; Aoki D
J Gynecol Oncol; 2018 May; 29(3):e29. PubMed ID: 29400022
[TBL] [Abstract][Full Text] [Related]
29. Evidence for breast cancer as an integral part of Lynch syndrome.
Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K
Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109
[TBL] [Abstract][Full Text] [Related]
30. New EPCAM founder deletion in Polish population.
Dymerska D; Gołębiewska K; Kuświk M; Rudnicka H; Scott RJ; Billings R; Pławski A; Boruń P; Siołek M; Kozak-Klonowska B; Szwiec M; Kilar E; Huzarski T; Byrski T; Lubiński J; Kurzawski G
Clin Genet; 2017 Dec; 92(6):649-653. PubMed ID: 28369810
[TBL] [Abstract][Full Text] [Related]
31. [Hereditary non-polyposis colorectal cancer associated with hereditary gastric cancer. A case report.].
Castañeda-Argáiz R; González-Contreras QH; Medina-Franco H; Rodríguez-Zentner HA; Tapia-Cid de León H; Vergara-Fernández O
Rev Gastroenterol Mex; 2009; 74(3):256-8. PubMed ID: 19858019
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
[TBL] [Abstract][Full Text] [Related]
33. Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry.
Goldberg M; Bell K; Aronson M; Semotiuk K; Pond G; Gallinger S; Zbuk K
J Med Genet; 2017 Nov; 54(11):742-746. PubMed ID: 28779004
[TBL] [Abstract][Full Text] [Related]
34. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM
Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A
Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733
[TBL] [Abstract][Full Text] [Related]
35. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
36. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.
Renkonen-Sinisalo L; Sipponen P; Aarnio M; Julkunen R; Aaltonen LA; Sarna S; Järvinen HJ; Mecklin JP
Scand J Gastroenterol; 2002 May; 37(5):574-7. PubMed ID: 12059060
[TBL] [Abstract][Full Text] [Related]
37. Contribution of ultrasonography to endometrial cancer screening in patients with hereditary nonpolyposis colorectal cancer/Lynch syndrome.
Lécuru F; Huchon C; Metzger U; Bats AS; Le Frère Belda MA; Olschwang S; Puig PL
Int J Gynecol Cancer; 2010 May; 20(4):583-7. PubMed ID: 20686377
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary.
Kóder G; Olasz J; Tanyi JL; George E; Tóth L; Antal-Szalmás P; Nagy B; Bubán T; András C; Urbancsek H; Laczik M; Csuka O; Damjanovich L; Tanyi M
J Gastrointest Cancer; 2020 Sep; 51(3):1007-1015. PubMed ID: 31939059
[TBL] [Abstract][Full Text] [Related]
39. Gastric cancer in Lynch syndrome is associated with underlying immune gastritis.
Adar T; Friedman M; Rodgers LH; Shannon KM; Zukerberg LR; Chung DC
J Med Genet; 2019 Dec; 56(12):844-845. PubMed ID: 31055502
[No Abstract] [Full Text] [Related]
40. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
